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Secretory granule biogenesis is a piv-otal process for regulated release 
of hormones and neurotransmitters. 
A prominent example is the pancre-
atic β cell that secretes insulin, a major 
anabolic hormone controlling cellular 
metabolism upon nutrient availabil-
ity. We recently described a checkpoint 
mechanism that halts scission of nascent 
secretory granules at the trans-Golgi 
network (TGN) until complete loading 
of insulin is achieved. We demonstrated 
that the Bin/Amphiphysin/Rvs (BAR) 
domain-containing protein Arfaptin-1 
prevents granule scission until it is phos-
phorylated by Protein Kinase D (PKD). 
Arfaptin-1 phosphorylation releases its 
binding to ADP-rybosylation factor 
(ARF) allowing scission to occur. Lack 
of this control mechanism in β cells 
resulted in premature scission, genera-
tion of dysfunctional insulin granules 
and impaired regulated insulin secretion 
without affecting constitutive release of 
other transport carriers. Here we discuss 
two important questions related to this 
work: How might completion of granule 
loading be sensed by PKD, and how does 
Arfaptin-1 specifically regulate insulin 
granule formation in beta cells?
Endocrine cells are highly specialized 
factories tailored for production and 
release of hormones and signaling mol-
ecules. The pancreatic β cell constitutes 
one prominent member of this cell type 
that dedicates a significant portion of its 
total protein synthesis to production of 
the hormone insulin, a key regulator of 
metabolic homeostasis. The whole pro-
cess from synthesis of preproinsulin at 
the rough endoplasmatic reticulum to 
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packaging and storing of mature insulin 
in secretory granules (Fig. 1A) is remark-
ably efficient in β cells. The majority of 
cells degrade around 33% of newly syn-
thesized protein due to translation, fold-
ing, processing or targeting errors.1 In β 
cells, however, more than 99% of newly 
synthesized preproinsulin are successfully 
routed and packaged into secretory gran-
ules.2 This extremely effective machinery 
in β cells suggests that a series of qual-
ity control checkpoints safeguards proper 
granule generation from preproinsulin 
translation and folding up to proinsu-
lin sorting and formation of secretory 
granules.
Recent work of our laboratory unveiled 
how β cells ensure proper secretory gran-
ule biogenesis at the trans-Golgi network 
(TGN).3 We showed that Arfaptin-1 
controls insulin granule scission and 
proposed that it stabilizes the neck of 
budding secretory granules (Fig. 1B). 
Arfaptin-1 was reported to bind to curved 
membrane structures with its crescent 
shaped Bin/Amphiphysin/Rvs (BAR) 
domain.4,5 In addition to curved mem-
branes, Arfaptin-1 also binds to activated 
small GTPases of the ARF family.6-8 
Binding of Arfaptin-1 to ARF blocks the 
small GTPase’s ability to recruit and acti-
vate downstream effectors.3,9,10 Thus, the 
effect of Arfaptin-1 on neck stability can 
be 2-fold. On the one hand, Arfaptin-1 
could generate a scaffold on the vesicle 
neck that provides mechanical support as 
has been suggested for other BAR domain 
proteins.5,11 On the other hand, it prevents 
active ARFs to induce fission by dimer-
ization or recruitment of a fission com-
plex.12-14 Once granule loading is complete 
and all necessary components have been 
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necessary for PKD-dependent release of 
nascent secretory granules from the TGN.
Today more than 130 insulin granule 
proteins have been described, half of which 
are transmembrane proteins.20 These pro-
teins may help to concentrate insulin in 
granules (e.g., granins21) or recruit the 
partial clathrin coat to the growing bud 
(e.g., Phogrin22). The changing surface 
protein composition during nascent gran-
ule growth may induce PKD activity by 
clustering of PKC interaction partners. 
PKCs rely on receptors for activated C 
kinases (RACKs) for proper localization 
to specific subcellular compartments.23 
One example is coatomer protein complex 
subunit β-2 (COPB2), which has been 
shown to recruit active novel PKCε to 
COPI-coated vesicles.24 A similar mecha-
nism could apply for secretory granules, 
although a granule specific RACK has not 
yet been identified.
How Can PKD Induce Scission 
of Insulin Granules at the Right 
Time?
A mechanism that is to trigger timely 
release of a growing secretory granule bud 
from the TGN should sense one or more 
features that indicate the loading status 
of the transport carrier. Such features 
include surface protein composition, lipid 
composition and granule size. Hence, the 
question arises how PKD may sense these 
features of a growing insuling granule and 
how its activation might occur at the right 
time? PKD is recruited to membranes by 
diacylglycerol (DAG). At the same time, 
DAG activates novel Protein Kinase Cs 
(nPKCs) the main upstream activators of 
PKD. nPKCs phosphorylate PKD at two 
regulatory sites and induce full enzymatic 
activity.19 Thus, both presence of DAG and 
phosphorylation by upstream kinases are 
sorted in, inhibition of scission has to be 
ceased to allow detachment of granules 
from the TGN. We demonstrated that 
release of this inhibition is accomplished 
by Protein Kinase D (PKD),3 a kinase 
that we discovered to be implicated in 
insulin secretion,15 which was confirmed 
in several subsequent studies.16-18 PKD 
phosphorylates Arfaptin-1 at a serine resi-
due close to its BAR domain, which disso-
ciates the Arfaptin-1 – ARF complex and 
allows secretory granule scission to occur 
(Fig. 1C). Interestingly, this mechanism is 
important for regulated release of insulin 
but does not affect constitutive secretion 
in β cells. Although the core components 
of this checkpoint mechanism have been 
identified, two main questions remain 
open: How can a loaded granule activate 
PKD and what confers specificity of this 
mechanism to insulin granule formation 
in β cells?
Figure 1. Insulin granule biogenesis—Model for PKd activation and Arfaptin-1 action. (A) Preproinsulin is cotranslationally inserted into the endoplas-
matic reticulum (er) and cleaved into proinsulin. Proinsulin is transported to the Golgi apparatus, where it is packaged into secretory granules at the 
trans-Golgi network (tGn). Immature insulin granules are covered by a discontinuous clathrin coat, which facilitates outsorting of granule compo-
nents during the maturation process. Constitutive-like vesicles bud off the maturing granules and return to the Golgi or are degraded by lysosomes. 
during the maturation process, which is accompanied by increasing acidification of the granule, proinsulin is converted into c-peptide and insulin, 
which crystallizes in the mature granule. (B) Arfaptin-1 dimers bind to active, GtP-bound ArF at the neck of nascent granule precursors and are likely 
to form a scaffold that provides mechanical support. At the same time ArFs are shielded from dimerization and interaction with downstream effec-
tors. (C) during loading of the nascent granule precursor an unknown receptor of activated C kinase (rACK) could accumulate at the granule surface, 
which binds active novel Protein Kinase C (nPKC). nPKC phosphorylates and activates Protein Kinase d (PKd), which is recruited upon diacylglycerol 
(dAG) accumulation in the neck. PKd phosphorylates in turn Arfaptin-1 and disrupts the Arfaptin-1-ArF complex. ArFs are free to dimerize and inter-
act with downstream partners leading to neck destabilization and granule fission.
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possibility is that Arfaptin-1 is recruited 
first to the neck and recruits ARF-GTP 
in a second step. Although this model 
cannot be fully excluded at this point, 
some experimental evidence speaks 
against requirement of Arfaptin-1 
to localize ARFs to the vesicle neck. 
Arfaptin-1 knockdown leads to the for-
mation of smaller, non-functional gran-
ules that in majority are rapidly degraded. 
This is most likely a result of an uncon-
trolled scission machinery.3 If Arfaptin-1-
mediated ARF recruitment to the vesicle 
neck was required for membrane separa-
tion, blockage of granule scission would 
have been expected. Thus, it is more 
probable that Arfaptin-1 binds initially 
to ARFs, which are already present on 
the granule neck. As a single Arfaptin 
dimer can bind two ARFs,29 more active 
ARFs would be recruited to the neck 
while the scaffold is growing. The scaf-
fold organizes GTP bound ARF in a 
regular pattern, while keeping it inactive. 
Once the Arfaptin-1 is released by PKD 
phosphorylation, active ARFs remain in 
close proximity to each other around the 
granule neck, which could induce rapid 
membrane fission by ARF dimerization 
or fission complex recruitment.
Interestingly, dense-core secretory gran-
ule biogenesis in many endocrine cells and 
neurons closely resembles insulin granule 
formation.35 Thus, a role of Arfaptin-1 in 
quality control of other secretory granules 
is quite likely. Arfaptin-1 could also be 
involved in constitutive secretion of more 
bulky cargoes such as collagen that require 
much bigger transport carriers. Studies in 
Arfaptin-1 knockout mice will be useful 
to shed light on the role of Arfaptin-1 in 
different tissues and the physiologic con-
sequences of its loss.
We are only starting to grasp the impor-
tance of BAR domain proteins in differ-
ent cellular processes. Understanding the 
mechanisms that provide a specific func-
tion for Arfaptin-1 in insulin granule for-
mation and that regulate PKD activity at 
the neck will provide new insights into the 
pivotal, yet elusive, process of secretory 
granule biogenesis at the TGN.
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How is Specificity for Regulated 
Secretion Achieved in β Cells?
Interestingly, our data shows that Arfaptin-1 
is necessary for regulated release of insulin 
but not constitutive secretion in β cells.3 
Yet, both regulated and constitutive trans-
port carriers generate neck structures dur-
ing their budding from the TGN. Thus, 
the question is how the BAR domain-con-
taining protein can distinguish one vesicle 
neck from the other. While the involve-
ment of other proteins in specific targeting 
of Arfaptin-1 cannot be excluded at this 
point, the unique binding characteristics 
of Arfaptin-1 might provide an answer. A 
structural study on the closely related pro-
tein Arfaptin-2 has revealed that Arfaptins 
can cooperatively bind small GTPases of 
the ARF family and curved membranes.29 
In addition, our own and others’ data 
have shown that Arfaptins bind to ARFs 
only in their active, GTP-bound state.3,6,7 
Yet, binding to active ARFs cannot help 
Arfaptin-1 to distinguish an insulin gran-
ule bud from a constitutive vesicle neck, as 
ARFs play an important role in formation 
and scission of both types of transport car-
riers.3,12-14,30,31 However, a clear difference 
of vesicles that are constitutively released 
from the Golgi and insulin granules is their 
size and thus membrane curvature. While 
Golgi-derived transport carriers, that are 
constitutively released, have an approxi-
mate diameter of 60–80 nm,32,33 insulin 
secretory granules are around 350 nm.34 
Consequently, the neck structures also 
differ in size. When expressing the non-
phosphorylatable Arfaptin-1 S132A mutant 
in β cells, we observed incompletely sepa-
rated insulin granules with stabilized neck 
structures that connected them with each 
other or to the TGN. These necks were 
around 50–60 nm in diameter and thus 
much bigger than the neck of the average 
constitutive transport carrier. Interestingly, 
Arfaptin has been shown to shape lipo-
somes into tubules of approximately the 
same diameter.4 Therefore, Arfaptin-1’s 
affinity for curved membranes of a certain 
diameter could explain the observed speci-
ficity for growing insulin granules.
Although it is established that 
Arfaptin-1 can bind both curved mem-
branes and ARF family members, the 
order of events is not clear yet. One 
PKD activity at the granule neck can 
be regulated at the level of upstream acti-
vation by PKC and/or at the level of PKD 
recruitment. Both changed lipid compo-
sition and size-dependent steric properties 
of the vesicle neck could directly control 
PKD recruitment. The best candidate 
molecule in this process is DAG. Due 
to its unique cone-like shape, DAG is 
preferably found in membranes with an 
extremely large negative curvature.25,26 
The negative curvature at the neck of a 
growing granule bud increases with the 
size of the vesicle, which allows for local 
DAG incorporation. Even without ele-
vated DAG production, the tropism of 
residual DAG for the vesicle neck would 
cause local accumulation by diffusion. 
Growth of the granule bud by continu-
ous cargo incorporation could induce 
local PKD recruitment at the neck of the 
granule once a certain size and thus mem-
brane curvature has been reached. PKD 
activation releases Arfaptin-1 from ARF 
and scission can occur. Such indirect size 
sensing mechanism would guarantee that 
insulin granule precursors are not prema-
turely released from the TGN and con-
tain the appropriate amount of peptide 
hormone.
The origin of DAG at the Golgi is still a 
matter of debate. However, a recent report 
corroborates conversion of phosphati-
dylcholine and ceramide into DAG and 
sphingomyelin as one important source.27 
Interestingly, ceramide homeostasis at 
the Golgi may be under direct control of 
PKD, as the kinase phosphorylates and 
inhibits CERT, an ER to Golgi ceramide 
shuttling protein.28 Thus, this phosphory-
lation might provide a negative feedback 
loop that limits the duration of local PKD 
activity and resets the system. While the 
DAG centered model of PKD recruitment 
is attractive, future studies will have to 
show whether local DAG accumulation is 
indeed sufficient to localize the kinase to 
secretory granule necks.
As extracellular signals such as acetyl-
choline, can induce PKD activity in β 
cells,3,15,17 it would be interesting to see 
whether the rate of insulin granule fis-
sion can be modulated by environmental 
stimuli and whether such signaling plays 
an important role in times of high secre-
tory demand.
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